Docket Number: FDA-2020-D-2107 Issued by: Guidance Issuing Office Center for Biologics Evaluation and Research Center for Drug Evaluation and Research Drug approvals in oncology often build […]
[11-8-2022] Health care professionals should be cautious of possible xylazine inclusion in fentanyl, heroin, and other illicit drug overdoses, as naloxone may not be able to […]
Delivery Method: VIA Electronic Mail Product: Drugs Recipient: Recipient Name Ruben De Quesada Recipient Title General Manager Omega & Delta Co., Inc. Carr. 887 Km 0 […]
Delivery Method: VIA UPS Product: Drugs Recipient: Recipient Name Mr. Shan Umer Recipient Title President The Anthos Group, Inc. 705 N Douglas StreetEl Segundo, CA 90245United […]
Delivery Method: VIA EMAIL CONFIRMED DELIVERY Product: Drugs Recipient: Recipient Name Mr. Giovanni Caforio Recipient Title Chief Executive Officer Abraxis Bioscience LLC 620 N 51st Ave.Phoenix, […]
Submit Comments by 01/08/2023 Although you can comment on any guidance at any time (see 21 CFR 10.115(g)(5)), to ensure that the FDA considers your comment […]
Joan: Welcome to the CDER Small Business and Industry Assistance (SBIA) Chronicles Podcast Series. Today’s topic: The FDA Compounding Incidents Program: Adverse Events Associated with Compounded […]
On average, FDA determines that the vast majority of all expanded access requests may proceed. Sometimes called “compassionate use”, expanded access is a potential pathway for […]
Summary Company Announcement Date: November 05, 2022 FDA Publish Date: November 07, 2022 Product Type: Drugs Reason for Announcement: Recall Reason Description Presence of methanol Company […]
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPTReject
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.